Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Darma Henwa Tbk (DEWA) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Darma Henwa TbkTrade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Darma Henwa Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Darma Henwa Tbk trades at Rp446 (market cap 18.96T, 523.31M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume). The key difference: Darma Henwa Tbk is far larger — about 29.8× UBC Medical Indonesia Tbk.'s market cap, and Darma Henwa Tbk is more actively traded (523.31M versus 843K). Which is the better fit depends on your goals.

DEWALABS
Market Cap
18.96T635.95B
Volume
523.31M843K
Lot
5.23M8.43K
Turnover
237.86B137.6M
Average Price
454.53163.22
Value
237.86B137.6M
Indicative Equilibrium Price
446165
Indicative Equilibrium Volume
145.01K246

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DEWA
View details
LABS
View details

About Darma Henwa Tbk

Darma Henwa Tbk (the Company) was established on 8 Oct 1991 based on Notaries Deed No.54, then changed to PT HWE Indonesia on Jan 2005. The Company started its commercial operations on 1993 with early main bussines in mining, and machine and equipment leasing. At Sep 5, 2005 company's name changed to PT Darma Henwa.

Read more on DEWA

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS